(RTTNews) – Europe’s major inventory markets rose dramatically on Monday, generating a wave of optimism about hopes for a coronavirus remedy in the face of the resurgence of virus cases around the world.
Investor sentiment was reinforced after U.S. regulators legalized the use of blood plasma from patients re-established as a remedy option for COVID-19, leading markets to stop a two-day drop.
Germany’s DAX up 301.74 points, or 2.36% to 13066.54, while the FTSE in London rose 102.84 points, or 1.71%, to 6104.73 and CAC 40 in France up 111.56 points, or 2.28%, to 5,007.89.
In Germany, Deutsche Bank rose 4.43%, while Daimler rose 4.02%, Heidelberg Cement rose 3.93%, Wirecard fell 3.70%, Covestro rose 3.21%, Siemens up 2.88%, Deutsche Borse rose 2.43%, Deutsche Telekom by 2.19% and thyssenkrupp won 1.60. %, Deutsche Lufthansa rose 1.44% and Deutsche Post by 1.28%.
In France, Societe Generale rose 4.19%, Peugeot up 3.94%, Veolia Environment accelerated to 3.56%, Crédit Agricole rose 2.90%, BNP Paribas rose 2.62%, Carrefour rose 1.51%, Sanofi 1.26%, Vivendi 1.00% and Accor fell 0.49. Percent.
On the commercial front, Moderna, Inc. (MRNA) said it had concluded complex exploratory talks with the European Commission to supply 80 million doses of mRNA-1273, the company’s COVID-19 candidate vaccine. The prospective procurement agreement gives Member States the option to purchase an additional 80 million doses for a total of up to 160 million doses.
The British store Tesco plc (TSCO. L, TSCDY. PK) will create 16,000 new permanent positions for the exceptional expansion of its online business, announced this Monday the corporation. These jobs are in addition to the 4,000 permanent jobs already created since the start of the COVID-19 pandemic.